<h3>享受 TipRanks Premium 50% 折扣，自信投资</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，帮助您做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，使您的投资组合始终处于最大潜力的状态</li>
</ul>
<p>CSL（ (AU:CSL) ）的公告现已发布。</p>
<p>CSL Limited 宣布了其持续股票回购计划的最新进展，透露在前一天之前共回购了 2,773,525 股普通全额支付证券，并在前一天额外回购了 46,950 股证券。此次回购举措是 CSL 有效管理其资本结构的战略的一部分，可能会提升股东价值并巩固其市场地位。</p>
<p>（AU:CSL）股票的最新分析师评级为买入，目标价格为 256.00 澳元。要查看 CSL 股票的完整分析师预测列表，请访问 AU:CSL 股票预测页面。</p>
<p><strong>关于 CSL 的更多信息</strong></p>
<p>CSL Limited 在生物技术行业运营，专注于创新生物治疗和流感疫苗的开发与交付。该公司是血浆衍生疗法的全球领导者，在全球多个市场运营，为罕见和严重疾病的患者提供必需药物。</p>
<p><strong>年初至今价格表现：</strong> -33.39%</p>
<p><strong>平均交易量：</strong> 1,150,052</p>
<p><strong>技术情绪信号：</strong> 卖出</p>
<p><strong>当前市值：</strong> 892.3 亿澳元</p>
<p>在 TipRanks 的股票分析页面了解更多关于 CSL 股票的信息。</p>

<p>CSL Limited 宣布了其股票回购计划的最新进展，回购了 2,773,525 股普通证券，最近又回购了 46,950 股。该举措旨在管理资本结构并提升股东价值。CSL 主要从事生物技术，专注于生物疗法和疫苗。尽管年初至今股价表现为 -33.39%，该股票仍被给予买入评级，目标价为 256.00 澳元</p>

<h3>Claim 50% Off TipRanks Premium and Invest with Confidence</h3>
<div class="lb-trans"><h3>享受 TipRanks Premium 50% 折扣，自信投资</h3>
</div><ul>
<li>Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，帮助您做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，使您的投资组合始终处于最大潜力的状态</li>
</ul>
</div><p>An announcement from CSL ( (AU:CSL) ) is now available.</p>
<div class="lb-trans"><p>CSL（ (AU:CSL) ）的公告现已发布。</p>
</div><p>CSL Limited has announced an update on its ongoing share buy-back program, revealing that a total of 2,773,525 ordinary fully paid securities have been repurchased before the previous day, with an additional 46,950 securities bought back on the previous day. This buy-back initiative is part of CSL’s strategy to manage its capital structure effectively, potentially enhancing shareholder value and reinforcing its market position.</p>
<div class="lb-trans"><p>CSL Limited 宣布了其持续股票回购计划的最新进展，透露在前一天之前共回购了 2,773,525 股普通全额支付证券，并在前一天额外回购了 46,950 股证券。此次回购举措是 CSL 有效管理其资本结构的战略的一部分，可能会提升股东价值并巩固其市场地位。</p>
</div><p>The most recent analyst rating on (AU:CSL) stock is a Buy with a A$256.00 price target. To see the full list of analyst forecasts on CSL stock, see the AU:CSL Stock Forecast page.</p>
<div class="lb-trans"><p>（AU:CSL）股票的最新分析师评级为买入，目标价格为 256.00 澳元。要查看 CSL 股票的完整分析师预测列表，请访问 AU:CSL 股票预测页面。</p>
</div><p><strong>More about CSL</strong></p>
<div class="lb-trans"><p><strong>关于 CSL 的更多信息</strong></p>
</div><p>CSL Limited operates in the biotechnology industry, focusing on the development and delivery of innovative biotherapies and influenza vaccines. The company is a global leader in plasma-derived therapies and operates in various markets worldwide, providing essential medicines to patients with rare and serious conditions.</p>
<div class="lb-trans"><p>CSL Limited 在生物技术行业运营，专注于创新生物治疗和流感疫苗的开发与交付。该公司是血浆衍生疗法的全球领导者，在全球多个市场运营，为罕见和严重疾病的患者提供必需药物。</p>
</div><p><strong>YTD Price Performance:</strong> -33.39%</p>
<div class="lb-trans"><p><strong>年初至今价格表现：</strong> -33.39%</p>
</div><p><strong>Average Trading Volume:</strong> 1,150,052</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 1,150,052</p>
</div><p><strong>Technical Sentiment Signal:</strong> Sell</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 卖出</p>
</div><p><strong>Current Market Cap:</strong> A$89.23B</p>
<div class="lb-trans"><p><strong>当前市值：</strong> 892.3 亿澳元</p>
</div><p>Learn more about CSL stock on TipRanks’ Stock Analysis page.</p>
<div class="lb-trans"><p>在 TipRanks 的股票分析页面了解更多关于 CSL 股票的信息。</p>
</div>

CSL 有限公司更新股票回购进展